Rhön-Klinikum AG Stock
Rhön-Klinikum AG Stock
A loss of -1.610% shows a downward development for Rhön-Klinikum AG.
Pros and Cons of Rhön-Klinikum AG in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhön-Klinikum AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhön-Klinikum AG | -1.610% | -0.800% | -5.344% | -16.216% | -2.362% | -4.615% | -20.103% |
| Chemed Corp. | 0.000% | -6.509% | -8.671% | -39.231% | -13.187% | - | - |
| Select Medical Holdings | 0.740% | 0.000% | -0.725% | -4.196% | 9.600% | -45.635% | -53.082% |
| Davita Inc. | -3.000% | -3.733% | -7.756% | -5.515% | 27.022% | 60.382% | 35.539% |
Comments
News
EQS-News: RHÖN-KLINIKUM AG with consistent development in financial year 2025
EQS-News: RHÖN-KLINIKUM AG with consistent development in financial year 2025
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025
EQS-News: RHÖN-KLINIKUM AG closes third quarter of 2025 with solid results
EQS-News: RHÖN-KLINIKUM AG closes third quarter of 2025 with solid results